Govt grants pharma industry 12-month extension for implementing revised Schedule M

The government has extended the deadline for pharma companies to implement updated quality standards by 12 months. This extension helps smaller manufacturers upgrade facilities and meet revised Schedule M requirements. The industry initially sought a two-year extension to address challenges. Firms must now comply with improved manufacturing practices by December 31, 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tLxlnXP
via IFTTT